Navigator™ is a new cardiovascular care system for circulatory management of critically ill patients. The care of such patients is complex, expensive and often very difficult. While there is no shortage of measurement in intensive and critical care, there is an astonishing lack of clinical decision support to assist clinicians and systematise care.
The Navigator technology from Sydney and London based Applied Physiology Pty Ltd, addresses the problem of clinician cognitive overload by simplifying the cardiovascular care of critical patients.
Raw data is acquired from conventional monitoring devices. These data are then used to calculate volume, resistance and cardiac output – key parameters that help clinicians to understand and manage cardiovascular performance. The interpreted data is then presented graphically on a bedside touch screen. The graph shows the patient’s status
relative to clinician defined targets. In this way the care team is able to closely plan and monitor the effect of interventions.
Navigator is useful in any situation in which resuscitation, stabilization and optimization of hemodynamic and oxygen metabolism is required, including ICU, OR and emergency medicine.
Safety and effectiveness were established in a 2008 multi-centre randomised controlled trial.
“Navigator has great potential to revolutionise the care of critically-ill patients by enabling a systematic and protocol-based approach to care. We are excited to present Navigator at Medica in preparation for market launch in 2010. Medica is an important international forum for connecting with distributors and strategic partners. “ says Applied Physiology CEO, Mark Leaning PhD.
Applied Physiology will exhibit at the annual MEDICA conference in Düsseldorf 18-21 November, 2009. To see Navigator or meet with company executives visit the Australian Pavilion, Hall 17 Stand B58 or see: www.appliedphysiology.com
This device is not available for sale or distribution. Regulatory applications have been lodged.